Risk of Abnormal Pregnancy Completing Chemotherapy for Gestational Trophoblastic Tumor

    June 2003 in “ Obstetrical & Gynecological Survey ”
    Hideo Matsui, Yoshinori Iitsuka, Kiyomi Susuka, Koji Yamazawa, Naotake Tanaka, Kazuhiko Seki, Souei Sekiya
    Image of study
    TLDR After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.
    The document presents several studies conducted 20 years ago. One study on 76 women found that the Michigan four-wall sacrospinous suspension was an effective treatment for post-hysterectomy vaginal vault prolapse. Another study on 387 patients found that normal pregnancy rates can be expected after chemotherapy for gestational trophoblastic tumor (GTT), but the risk of another GTT in a subsequent pregnancy is slightly increased. It also suggested that patients should wait 12 months before attempting another pregnancy. A trial on 17 nonobese women with Polycystic Ovary Syndrome (PCOS) found that metformin reduced hyperinsulinemia and hyperandrogenism, offering an effective treatment for anovulation. A study on 36 premenopausal, hyperandrogenic women found that flutamide led to modest improvement in alopecia after 1 year. Another study on 35 ovulatory women found that the start day of clomiphene therapy for infertility does not affect oocyte quality or endometrial receptivity. Lastly, a study found that postmenopausal ovaries neither synthesize nor secrete androgens, suggesting that the adrenal gland might be the source of postmenopausal androgens.
    Discuss this study in the Community →

    Related Community Posts Join

    2 / 2 results

      community Certified old, at 51, balding since 25, the resurrection!

      in Progress Pictures  439 upvotes 1 month ago
      A 51-year-old shared progress on hair regrowth using topical Minoxidil and Finasteride over four months, noting significant improvement and plans for future hair transplants. The user emphasized the benefits of modern treatments and societal changes in attitudes towards hair loss.

      community Verteporfin and Microneedling

      in Treatments 6 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

    Similar Research

    5 / 1000+ results